Clinical and bacteriological efficacy in treatment of acute exacerbations of chronic bronchitis with cefditoren-pivoxil versus cefuroxime-axetil
about
Antibiotics for exacerbations of chronic obstructive pulmonary diseaseCrystal Structure of Cefditoren Complexed with Streptococcus pneumoniae Penicillin-Binding Protein 2X: Structural Basis for Its High Antimicrobial ActivityThe management of acute bronchitis in childrenHigh protein binding and cidal activity against penicillin-resistant S. pneumoniae: a cefditoren in vitro pharmacodynamic simulationCefditoren in upper and lower community-acquired respiratory tract infectionsDrug resistance in community-acquired respiratory tract infections: role for an emerging antibacterial.Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results.Cefditoren versus levofloxacin in patients with exacerbations of chronic bronchitis: serum inflammatory biomarkers, clinical efficacy, and microbiological eradication.Efficacy of amoxycillin versus amoxycillin/clavulanate in acute exacerbations of chronic pulmonary obstructive disease in primary careNew semiphysiological absorption model to assess the pharmacodynamic profile of cefuroxime axetil using nonparametric and parametric population pharmacokinetics.Efficacy and safety of 3 day versus 7 day cefditoren pivoxil regimens for acute uncomplicated cystitis: multicentre, randomized, open-label trial.Antibiotic susceptibility of respiratory pathogens recently isolated in Italy: focus on cefditoren.Antibacterial activity of cefditoren against major community-acquired respiratory pathogens recently isolated in Italy.Update of the activity of cefditoren and comparator oral beta-lactam agents tested against community-acquired Streptococcus pneumoniae isolates (USA, 2004-2006).Revisiting cefditoren for the treatment of community-acquired infections caused by human-adapted respiratory pathogens in adults
P2860
Q24202248-154386DA-81E0-4010-B317-0A6FA441A362Q27647586-BA5ACDF2-1810-4A3F-90E3-DFF5B3BFCCBBQ28288887-6448FE3B-6C3A-46CA-99D1-CEEFD9FB249AQ28473173-FA03DA8E-D752-45DB-8DAC-2B2FC032B726Q34574090-7A2FE736-3A1B-452E-8B1B-B8338BA34D80Q35026577-2632B5E6-F177-40C1-9DDF-CF847E0006D9Q36087058-CC5976A7-E48F-4247-AB31-CCB37670661FQ36617992-AD6E9508-1A66-4AB2-A8C8-28CA94F756FAQ37168358-F05A425B-AD83-4087-A82E-E196C440AC50Q37274639-44F6A917-C49F-430A-8770-5A32522EDB87Q40509034-DA85939D-FD39-46ED-9759-EDC003422EF0Q43010590-715AA6E2-A12B-4BF6-84E7-E1658E40FA48Q46231687-6AA0E71D-2C45-423F-9F2C-3B03008593ADQ46604541-BFB627EE-7AC2-4710-AC00-E52DC1BD4F7BQ58617498-B2F42C10-408F-49B7-9C32-A75C7843E933
P2860
Clinical and bacteriological efficacy in treatment of acute exacerbations of chronic bronchitis with cefditoren-pivoxil versus cefuroxime-axetil
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Clinical and bacteriological e ...... voxil versus cefuroxime-axetil
@ast
Clinical and bacteriological e ...... voxil versus cefuroxime-axetil
@en
Clinical and bacteriological e ...... voxil versus cefuroxime-axetil
@nl
type
label
Clinical and bacteriological e ...... voxil versus cefuroxime-axetil
@ast
Clinical and bacteriological e ...... voxil versus cefuroxime-axetil
@en
Clinical and bacteriological e ...... voxil versus cefuroxime-axetil
@nl
prefLabel
Clinical and bacteriological e ...... voxil versus cefuroxime-axetil
@ast
Clinical and bacteriological e ...... voxil versus cefuroxime-axetil
@en
Clinical and bacteriological e ...... voxil versus cefuroxime-axetil
@nl
P2093
P2860
P1476
Clinical and bacteriological e ...... voxil versus cefuroxime-axetil
@en
P2093
Jesús Martínez-Beltrán
Jose-Luis Alvarez-Sala
Lorenzo Aguilar
Peter Kardos
Pilar Coronel
P2860
P304
P356
10.1128/AAC.50.5.1762-1767.2006
P407
P577
2006-05-01T00:00:00Z